PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4866 (116th)

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020

referredUnited States· United States Congress· EN

Introduced

28 October 2019

Last action

—

Status

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsors

—

Subjects

Discovery layer

Source updated

28 May 2025

Official sourceDownload fileView documentsShare

Summary

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2019 This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

10 official files

Referred in Senate (text)

View fileDownload file

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.